On November 2, InnoCare fell for 9 consecutive trading days, with a cumulative decline of -12.61%. InnoCare Pharma Limited SSE code: 688428; HKEX code: 09969) is a commercial-stage biopharmaceutical high-tech company, co-founded in 2015 by Dr. Cui Jisong, who has rich experience in new drug research and development and corporate management, and Academician Shi Yigong, a world-renowned structural biologist.

According to the financial report, Penghua Pharmaceutical Technology Stock A, a subsidiary of Penghua Fund, is one of the top ten shareholders of InnoCare and remains unchanged in the third quarter of this year. The year-to-date yield is -9.35%, ranking 794 in the same category (out of 929).

The fund manager of Penghua Pharmaceutical Technology Stock A is Jin Xiaofei.

According to the resume, Mr. Jin Xiaofei: nationality Chinese, master's degree in economics. In July 2012, he joined Penghua Fund Management Co., Ltd., engaged in industry research, successively served as fund manager assistant/senior researcher in the research department, and is currently the deputy general manager/fund manager of the second equity investment department. In 2016-06, he served as the manager of Penghua Pharmaceutical Technology Equity Fund, from 2017-07 to 2020-03, from 2017-07 to 2020-03, from 2019-06 to 2022-06, he served as the manager of Penghua Science and Technology 3-year closed-end mixed fund, in 2021-06, he served as the manager of Penghua Innovation and Upgrading Mixed Fund, and from 2022-06 to 2024-05-17, he served as the manager of Penghua Innovation Power Hybrid (LOF) Fund. In June 2022, he served as the manager of Penghua Innovation Growth One-year Holding Period Mixed Fund, and on April 27, 2024, he served as the fund manager of Penghua Pension Industry Equity Securities Investment Fund and the fund manager of Penghua Healthcare Equity Securities Investment Fund.

According to the data, Penghua Fund Management Co., Ltd. was established in December 1998, with Zhang Nasha as chairman and Deng Zhaoming as general manager. AT PRESENT, PENGHUA FUND HAS A TOTAL OF 3 SHAREHOLDERS, GUOSEN SECURITIES CO., LTD. HOLDS 50% OF THE SHARES, EURIZON CAPITAL SGR S.P.A HOLDS 49% OF THE SHARES, AND SHENZHEN BEIRONGXIN INVESTMENT DEVELOPMENT CO., LTD. HOLDS 1% OF SHARES.

Source: Finance